Isolation of suppressor genes that restore retrovirus susceptibility to a virus-resistant cell line

被引:7
作者
Gao G. [1 ,2 ]
Goff S.P. [1 ]
机构
[1] Dept. of Biochem./Molec. Biophysics, Howard Hughes Medical Institute, Columbia Univ. Coll. of Phys./Surg., New York
[2] Institute of Microbiology, Chinese Academy of Sciences
关键词
Virus Resistance; Virus Susceptibility; Virus Resistance Gene; VL30 Element; Amphotropic Envelope;
D O I
10.1186/1742-4690-1-30
中图分类号
学科分类号
摘要
Background: Genetic selections in mammalian cell lines have recently been developed for the isolation of mutant cells that are refractory to infection by retroviruses. These selections have been used to recover lines that block early postentry stages of infection, either before reverse transcription or before nuclear entry. The mechanisms of action of these blocks remain unknown. Results: We have devised a method for the selection of genes from cDNA libraries that suppress the block to virus infection, and so restore virus susceptibility. The protocol involves the transformation of pools of resistant cells by cDNA expression libraries, followed by the selection for rare virus-sensitive cells, using multiple rounds of selection after infection by marked viral vector genomes. The suppressor genes were then recovered from these virus sensitive cells, and their ability to restore virus susceptibility was confirmed by reintroduction of these cDNAs into the resistant line. Conclusions: The identities of these genes provide insights into the mechanism of virus resistance and will help to define new pathways used during retrovirus infection. The methods for gene isolation developed here will also permit the identification of similar suppressors that modify or override other recently identified virus resistance genes. © 2004 Gao and Goff; licensee BioMed Central Ltd.
引用
收藏
页数:10
相关论文
共 22 条
[1]  
Bieniasz P.D., Restriction factors: A defense against retroviral infection, Trends Microbiol., 11, pp. 286-291, (2003)
[2]  
Towers G.J., Goff S.P., Post-entry restriction of retroviral infections, AIDS Rev., 5, pp. 156-164, (2003)
[3]  
Lilly F., Pincus T., Genetic control of murine viral leukemogenesis, Adv. Cancer Res., 17, pp. 231-277, (1973)
[4]  
Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H., DNA deamination mediates innate immunity to retroviral infection, Cell, 113, pp. 803-809, (2003)
[5]  
Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J., The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys, Nature, 427, pp. 848-853, (2004)
[6]  
Gao G., Goff S.P., Somatic cell mutants resistant to retrovirus replication: Intracellular blocks during the early stages of infection, Mol. Biol. Cell, 10, pp. 1705-1717, (1999)
[7]  
Imai H., Chan E.K., Kiyosawa K., Fu X.D., Tan E.M., Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma, J. Clin. Invest., 92, pp. 2419-2426, (1993)
[8]  
Jung D.J., Na S.Y., Na D.S., Lee J.W., Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors, J. Biol. Chem., 277, pp. 1229-1234, (2002)
[9]  
Seed B., An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2, Nature, 329, pp. 840-842, (1987)
[10]  
Howk R.S., Troxler D.H., Lowy D., Duesberg P.H., Scolnick E.M., Identification of a 30S RNA with properties of a defective type C virus in murine cells, J. Virol., 25, pp. 115-123, (1978)